MEDWELLAI, INC.
Income Statement
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $618.7K | $548.3K | $96.1K | $169.4K | $281.3K | $142.9K | $1.1K | $-4.8M |
| Cost of Revenue | — | — | — | — | $0 | $0 | $0 | $721.3K |
| Gross Profit | — | — | — | — | $281.3K | $142.9K | $1.1K | $-5.5M |
| Gross Margin | — | — | — | — | 100.0% | 100.0% | 100.0% | 115.1% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $364.5K | $410.1K | $395.5K | $464.5K | $1.1M | $625.2K | $335.2K | $359.8K |
| Operating Income | $-227.9K | $-274.0K | $-326.0K | $-1.1M | $-814.2K | $-315.1K | $-589.0K | $1.3K |
| Operating Margin | -36.8% | -50.0% | -339.3% | -662.4% | -289.4% | -220.6% | -51,305.2% | 0.0% |
| Interest Expense | $12.7K | $13.6K | $12.9K | $13.5K | $12.7K | $13.0K | $13.1K | $13.0K |
| Pretax Income | $-240.7K | — | — | $-149.9K | $-826.9K | $-729.7K | $-1.2M | $-11.6K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-240.2K | $-287.5K | $-651.9K | $-1.1M | $-588.6K | $-673.9K | $-1.2M | $-2.4M |
| Net Margin | -38.8% | -52.4% | -678.4% | -666.0% | -209.2% | -471.7% | -105,927.4% | 49.9% |
| EPS (Basic) | $-0.04 | $-0.05 | $-0.09 | $-0.20 | $-0.10 | $-0.06 | $-0.13 | — |
| EPS (Diluted) | $-0.04 | $-0.05 | $-0.09 | $-0.13 | $-0.10 | $-0.13 | $-0.13 | — |
| Shares Outstanding (Basic) | 6.2M | 6.2M | 6.2M | 6.2M | 5.9M | — | 5.2M | 5.1M |
| Shares Outstanding (Diluted) | 6.2M | 6.2M | 6.2M | 6.2M | 5.9M | 5.3M | 5.2M | 5.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |